Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience
- 26 April 2016
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 21 (2) , 212-227
Abstract
Background Few studies have been conducted on the long-term prognosis of patients with amyloid light chain (AL) and amyloid A (AA) renal amyloidosis in the same cohort. Methods We retrospectively examined 68 patients with biopsy-proven renal amyloidosis (38 AL and 30 AA). Clinicopathological findings at the diagnosis and follow-up data were evaluated in each patient. We analyzed the relationship between clinicopathological parameters and survival data. Results Significant differences were observed in several clinicopathological features, such as proteinuria levels, between the AL and AA groups. Among all patients, 84.2 % of the AL group and 93.3 % of the AA group received treatments for the underlying diseases of amyloidosis. During the follow-up period (median 18 months in AL and 61 months in AA), 36.8 % of the AL group and 36.7 % of the AA group developed end-stage renal failure requiring dialysis, while 71.1 % of the AL group and 56.7 % of the AA group died. Patient and renal survivals were significantly longer in the AA group than in the AL group. eGFR of >60 mL/min/1.73 m2 at biopsy and an early histological stage of glomerular amyloid deposition were identified as low-risk factors. A multivariate analysis showed that cardiac amyloidosis and steroid therapy significantly influenced patient and renal survivals. Conclusions Our results showed that heart involvement was the major predictor of poor outcomes in renal amyloidosis, and that the prognosis of AA renal amyloidosis was markedly better than that in previously reported cohorts. Therapeutic advances in inflammatory diseases are expected to improve the prognosis of AA amyloidosis.Keywords
This publication has 24 references indexed in Scilit:
- Renal AmyloidosisClinical Journal of the American Society of Nephrology, 2013
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- AL Amyloidosis Associated with IgM Monoclonal Protein: A Distinct Clinical EntityClinical Lymphoma Myeloma and Leukemia, 2009
- Renal amyloidosis associated with extracapillary glomerulonephritis and vasculitis in a patient with inflammatory bowel disease treated with infliximabClinical Nephrology, 2008
- New advances in renal amyloidosisClinical and Experimental Nephrology, 2008
- Renal involvement in systemic amyloidosis: An Italian collaborative study on survival and renal outcomeNephrology Dialysis Transplantation, 2007
- Amyloidosis-Associated Kidney DiseaseJournal of the American Society of Nephrology, 2006
- Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable regionPathology International, 2006
- Amyloid A-type renal amyloidosis in a patient with sarcoidosis: report of a case and review of the literatureClinical Nephrology, 2003
- Nephrotic syndrome in a patient with renal amyloidosis due to polyangiitis overlap syndromeNephrology Dialysis Transplantation, 2002